SFPT Session 4 - Neuropsychopharmacology

17:00 • SS04-01 • Développement d'un traitement des neuropathies génétiques > F. Franck STURTZ 17:30 • 150 • Quercetin delivery system using molecular imprinting polymers based on biocompatible chitosan increase it bioavailability and long term antioxydant effect > L. Lauralie Debard 17:40 • 354 • Serious neuropsychiatric adverse drug reactions to montelukast in children: evidence from the French Pharmacovigilance Database > P-B. Paul-Benoît Fargier 17:50 • 36 • Trends of methylphenidate use in France: a population-based, monthly cross-sectional study > D. Diane MERINO 18:00 • 378 • OPIO-Trend : Impact of the 2022 guidelines from the French National Authority for Health on the appropriate use of opioid analgesics > M. Maryse LAPEYRE-MESTRE 18:10 • 4 • Modulation of striatal cAMP levels: A key pathway in the treatment of hyperkinetic movement disorders > L-L. Louise-Laure Mariani 18:20 • 492 • Preliminary pharmacokinetic investigation of two Discoidin Domain Receptors 2 (DDR2) inhibitors in murine plasma and brain using a LC-MS/MS analysis > P. Paul GUEROUE